CAS: 501692-44-0; (S)-2-((R)-2-(2-((3,3-Dibutyl-7-(Methylthio)-1,1-Dioxido-5-Phenyl-2,3,4,5-Tetrahydrobenzo[f][1,2,5]Thiadiazepin-8-yl)Oxy)Acetamido)-2-(4-Hydroxyphenyl)Acetamido)Butanoic Acid

该化合物是一种选择性的宫颈胆碱酸转移器(IBAT)抑制器,用于治疗累进家庭内胆固态(PICT)和其他胆固态肝病.通过抑制IBAT,它减少了在终端中再次吸附胆碱酸的情况,从而降低了系统的胆碱酸水平,并降低了相关的肝毒性.它的小型分子结构允许口服,提供了非外科治疗选择.临床研究表明,它在减少PICT病人的普里图斯和改善肝功能参数方面是有效的. Odevixibat特别突出其有针对性的行动机制和有利的安全特征,使它成为长期管理胆碱状况的一个可行选择.

结构式图片

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-12240808-B2
    优先权日:2021-05-28
    标 题 :Process for the synthesis of calebin-a and its intermediates
    发明人:MAJEED MUHAMMED; NAGABHUSHANAM KALYANAM; MUTHUKAMAN NAGARAJAN; NAIDU PENTAKOTA PARADESI
    权利人:MAJEED MUHAMMED; NAGABHUSHANAM KALYANAM; MUTHUKAMAN NAGARAJAN; NAIDU PENTAKOTA PARADESI
    摘要:The invention discloses novel intermediates in the synthesis of Calebin A represented by formula 3. The invention also covers processes for the synthesis of Calebin-A and its analogs using compounds of formula 3.

    专利号:US-10392361-B2
    优先权日:2016-01-21
    标题:Process for the synthesis of intermediates of Nebivolol
    发明人:BARTOLI SANDRA; MANNUCCI SERENA; GRISELLI ALESSIO; STEFANINI ALESSIO
    权利人:MENARINI INT OPERATIONS LUXEMBOURG SA
    摘要:The present invention relates to a novel process for the synthesis of the intermediate compounds constituted by chromanyl haloketones of formula III and 6-fluoro-2-(oxiran-2-yl)chromans of formula I. n The intermediates thus obtained can be used for the synthesis of Nebivolol.

    专利号:US-11401273-B2
    优先权日:2018-11-20
    标题:Asymmetric synthesis of Azaspiro compounds
    发明人:LELETI RAJENDER REDDY; WAMAN YOGESH; KALLURE PRIYA; BEGUM ZUBEDA; DIVYA THUMBAN; NALIVELA KUMARA SWAMY; VIJAY SAURABH; PARIKH PARANJAY; KOTTURI SHARADSRIKAR; PATEL CHIRAG; NAYAK KRISHNA; BAHAROONI KASIMRAZA; ZALAVADIYA VINKAL
    权利人:PIRAMAL PHARMA LTD
    摘要:The present invention relates to an improved asymmetric synthesis of azaspiro or diazaspiro compound (hereafter referred to as the compound 5, (5A) or (5N)) or their pharmaceutically acceptable salts and derivatives; through the formation of intermediate compounds 4, (4A) or (4N) respectively. The process comprises an unusual substrate specific highly diastereoselective as well as enantio-enriched 1-substituted 2-azaspiro[3.3]heptane or 1-substituted 2-diazaspiro[3.3]heptane compounds with high diastereoselectivity by addition of a cyclobutane carboxylate anion to a Davis-Ellman's imine, followed by reduction and cyclisation resulting in the selective formation of azaspiro or diazaspiro intermediate compound 4, (4A) or (4N); which on subsequently removing the sulfinyl group provides corresponding azaspiro or diazaspiro compound 5, (5A) or (5N) respectively.

    专利号:US-10647655-B2
    优先权日:2016-09-02
    标题:Method for the synthesis of permethrin
    发明人:PULLAGURLA MANIK REDDY; NANDA KUMAR MECHERIL VALSAN; VELIGETLA MADHUSUDHANA RAO; RANGISETTY JAGADEESH BABU
    权利人:BIOPHORE INDIA PHARMACEUTICALS PVT LTD
    摘要:An improved method for the synthesis of substantially pure Permethrin having purity greater than 99.5% by Gas Chromatography provided. The embodiments also relates to a purification process of Permethrin by recrystallization from methanol-water mixture.

    专利号:US-6027708-A
    优先权日:1998-09-08
    标 题:Process for the synthesis of flyash based zeolite-Y
    发明人:RAYALU SADHANA; LABHASETWAR NITIN KUMAR; KHANNA PURUSHOTTAM
    权利人:COUNCIL SCIENT IND RES
    摘要:The present invention relates to a process for the synthesis of flyash based zeolite-Y (FAZ-Y), comprising grainding and mixing of flyash with caustic soda in a ratio ranging between 1:0.4-1:1.2 to obtain a fine homogenous fusion mixture, heating the said fusion mixture in an invert vessel at about 500-600° C. for about 1-2 hours to obtain a fused mass, cooling, milling, and mixing of the said fused mass in distilled water for about 8-12 hours, subjecting the said slurry to hydrothermal crystallization at about 90-110° C. for 8 to 12 hours to obtain FAZ-Y crystals, washing the said crystals with water and then subjecting the washed crystals to oven drying at 50-60° C. to obtain the desired FAZ-Y crystals.

    专利号:US-9611255-B2
    优先权日:2015-06-10
    标题 :Process for total synthesis of flavonoid compounds and isomers thereof
    发明人:RAO BATCHU VENKATESWARA; LINGAMURTHY MACHA; RAJU Gurrapu; SARMA VANKA UMAMAHESWARA
    权利人:COUNCIL SCIENT IND RES; COUNCIL SCIENT IND RES
    摘要:The present invention relates to the a process for total synthesis of flavonoid compounds of general formula I and isomers thereof n nwherein R 1 and R 2 is OH; R 3 â•?H orn n n n n n n n n n n The present invention particularly relates to the process for preparation and separation of (2S,3S)-taxifolin-6-C-β-D-glucopyranoside (ulmoside A), (2R,3R)-taxifolin-6-C-β-D-glucopyranoside and taxifolin.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Komaniecka N, Maroszek S, Drozdzik M, Oswald S, Drozdzik M. Transporter Proteins as Therapeutic Drug Targets-With a Focus on SGLT2 Inhibitors. Int J Mol Sci. 2024 Jun 25;25(13):6926. doi: 10.3390/ijms25136926.
    2: Odevixibat (Bylvay): CADTH Reimbursement Review: Therapeutic area: Progressive familial intrahepatic cholestasis [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 May. Report No.: SR0788CL. 9(7):632-645. doi: 10.1016/S2468-1253(24)00074-8. Epub 2024 Apr 23. 16(3):e56886. doi: 10.7759/cureus.56886.
    5: Hof WFJ, de Boer JF, Verkade HJ. Emerging drugs for the treatment of progressive familial intrahepatic cholestasis: a focus on phase II and III trials. Expert Opin Emerg Drugs. 2024 Jul

    合成参考文献


    参考文献:10.1186/s12887-022-03208-2
    摘要:Song L, Jia Y, Ran S, Li B, Xu J, Huo B, Yin N, Ai M, Liu Y. Current situation of pediatric clinical trials in China: focus on trials for drug marketing application and administrative approval. BMC Pediatrics. 2022 Mar 18;22(1):144. doi: 10.1186/s12887-022-03208-2.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知